Exact Sciences (Genomic Health)
Exact Sciences acquired the US company Genomic Health at the end of 2019, following its success in Europe. A large part of this success was the reimbursement of its breast cancer test Oncotype DX®. Hello Healthcare had the pleasure of working for Genomic Health Germany for many years to achieve the goal of an EBM code* for Oncotype DX.
From 2012 to 2019, we orchestrated a combination of marketing, market access and medical affairs activities to achieve this goal:
- Medical education
- Payer strategies
- Public affairs activities
- Collaboration with patient advocacy groups
- Congress participation and symposia
- And much more
*An EBM code in the ambulatory care setting enables reimbursement for a medical service.
www.exactsciences.com